Treatment With Tralokinumab Improves Health-Related Quality of Life in Adult Patients With Moderate to Severe Atopic Dermatitis: Results from a Phase 2b, Randomised, Double-Blind, Placebo-Controlled Study. J of Skin 2018, 2, S64. https://doi.org/10.25251/skin.2.supp.64.